The Experts below are selected from a list of 777 Experts worldwide ranked by ideXlab platform
Natalie Litera - One of the best experts on this subject based on the ideXlab platform.
-
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corinne Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 for their medication each year. This article discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
-
Medication therapy management implementation, part 2: study methodologies, barriers, and recommendations to overcome barriers.
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corrine Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 in medication each year. This article presents the methodolgy used by authors to conduct a study of Indiana pharmacists to determine pharmacists' attitudes and prActices surrounding medication therapy management services. This article also discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
-
Recommendations for overcoming barriers to medication therapy management implementation, part 1: review of literature.
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corinne Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 in out-of-pocket expenses for their medication each year. This article serves as a literature review of medication therapy management services and serves as an introduction to a study conducted by the authors concerning some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
Joshua A Hirsch - One of the best experts on this subject based on the ideXlab platform.
-
Compliance and Documentation for Interventional Techniques
Essentials of Interventional Techniques in Managing Chronic Pain, 2018Co-Authors: Laxmaiah Manchikanti, Vijay P. Singh, Joshua A HirschAbstract:Compliance and documentation for interventional techniques have a multitude of regulations but are an essential part of medicine. Developments in the mid-1970s irrevocably affected the role of documentation in medicine as a result of a dramatic nationwide increase in medical liability claims and awards and changes in the fledgling Medicare program, followed by the emergence of electronic review progress in the 1980s. The Health Insurance Portability and Accountability Act (HIPAA), the Medicare Modernization Act (MMA), and the Affordable Care Act (ACA), each with numerous component regulations, propelled the growth and importance of documentation to an unimaginable level.
-
the impAct of comparative effectiveness research on interventional pain management evolution from Medicare Modernization Act to patient protection and affordable care Act and the patient centered outcomes research institute
Pain Physician, 2011Co-Authors: Laxmaiah Manchikanti, Helm S Nd, Allan T Parr, Frank J.e. Falco, Ramsin M. Benyamin, Joshua A HirschAbstract:: The Patient-Centered Outcomes Research Institute (PCORI) was established by the Affordable Care Act of 2010 to promote comparative effectiveness research (CER) to assist patients, clinicians, purchasers, and policy-makers in making informed health decisions by advancing the quality and relevance of evidence concerning the manner in which diseases, disorders, and other health conditions can effectively and appropriately be prevented, diagnosed, treated, monitored, and managed through research and evidence synthesis. The development of PCORI is vested in the Medicare Modernization Act (MMA) and the American Recovery and Reinvestment Act (ARRA). The framework of CER and PCORI describes multiple elements which are vested in all 3 regulations including stakeholder involvement, public participation, and open transparent decision-making process. Overall, PCORI is much more elaborate with significant involvement of stakeholders, transparency, public participation, and open decision-making. However, there are multiple issues concerning the operation of such agencies in the United States including the predecessor of Agency for Healthcare Research and Quality (AHRQ), the Agency for Healthcare Policy and Research (AHCPR), AHRQ Effectiveness Health Care programs, and others. The CER in the United States may be described at cross-roads or at the beginnings of a scientific era of CER and evidence-based medicine (EBM). However the United States suffers as other countries, including the United Kingdom with its National Health Services (NHS) and National Institute for Health and Clinical Excellence (NICE), with major misunderstandings of methodology, an inordinate focus on methodological assessment, lack of understanding of the study design (placebo versus Active control), lack of involvement of clinicians, and misinterpretation of the evidence which continues to be disseminated. Consequently, PCORI and CER have been described as government-driven solutions without following the principles of EBM with an extensive focus on costs rather than quality. It also has been stated that the central planning which has been described for PCORI and CER, a term devised to be acceptable, will be used by third party payors to override the physician's best medical judgement and patient's best interest. Further, stakeholders in PCORI are not scientists, are not balanced, and will set an agenda with an ultimate problem of comparative effectiveness and PCORI that it is not based on medical science, but rather on political science and not even under congressional authority, leading to unprecedented negative changes to health care. Thus, PCORI is operating in an ad hoc manner that is incompatible with the principles of evidence-based prActice.This manuscript describes the framework of PCORI, and the role of CER and its impAct on interventional pain management.
Jeremy P. Fyke - One of the best experts on this subject based on the ideXlab platform.
-
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corinne Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 for their medication each year. This article discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
-
Medication therapy management implementation, part 2: study methodologies, barriers, and recommendations to overcome barriers.
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corrine Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 in medication each year. This article presents the methodolgy used by authors to conduct a study of Indiana pharmacists to determine pharmacists' attitudes and prActices surrounding medication therapy management services. This article also discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
-
Recommendations for overcoming barriers to medication therapy management implementation, part 1: review of literature.
International journal of pharmaceutical compounding, 2008Co-Authors: Jeremy P. Fyke, Robert N. Yale, Corinne Corbett, Natalie LiteraAbstract:As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 in out-of-pocket expenses for their medication each year. This article serves as a literature review of medication therapy management services and serves as an introduction to a study conducted by the authors concerning some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
Brent K. Hollenbeck - One of the best experts on this subject based on the ideXlab platform.
-
Effects of the Medicare Modernization Act on Spending for Outpatient Surgery.
Health Services Research, 2017Co-Authors: John M. Hollingsworth, Mary K. Oerline, Chandy Ellimoottil, Lindsey A. Herrel, Brent K. HollenbeckAbstract:OBJECTIVES To examine the effects of Medicare's revised ambulatory surgery center (ASC) payment schedule on overall payments for outpatient surgery. DATA SOURCES Twenty percent sample of national Medicare beneficiaries. STUDY DESIGN We conducted a pre-post study of Medicare beneficiaries who underwent outpatient surgery in a hospital outpatient department (HOPD), ASC, or physician office between 2004 and 2011. Specifically, we used multivariable regression to compare temporal trends in outpatient surgery before and after implementation of Medicare's revised payment schedule in 2008, which reduced ASC facility payments to roughly two-thirds that of HOPDs. Our outcome measures included overall Medicare payments, utilization rates, per beneficiary spending, and average episode payments for outpatient surgery. PRINCIPAL FINDINGS Between the last quarters of 2007 and 2008, overall Medicare payments for outpatient surgery grew by $334 million-an amount nearly three times higher than would have been expected without the policy change (p
-
Effects of the Medicare Modernization Act on Spending for Outpatient Surgery.
Health services research, 2017Co-Authors: John M. Hollingsworth, Mary K. Oerline, Chandy Ellimoottil, Lindsey A. Herrel, Brent K. HollenbeckAbstract:To examine the effects of Medicare's revised ambulatory surgery center (ASC) payment schedule on overall payments for outpatient surgery. Twenty percent sample of national Medicare beneficiaries. We conducted a pre-post study of Medicare beneficiaries who underwent outpatient surgery in a hospital outpatient department (HOPD), ASC, or physician office between 2004 and 2011. Specifically, we used multivariable regression to compare temporal trends in outpatient surgery before and after implementation of Medicare's revised payment schedule in 2008, which reduced ASC facility payments to roughly two-thirds that of HOPDs. Our outcome measures included overall Medicare payments, utilization rates, per beneficiary spending, and average episode payments for outpatient surgery. Between the last quarters of 2007 and 2008, overall Medicare payments for outpatient surgery grew by $334 million-an amount nearly three times higher than would have been expected without the policy change (p < .001 for the difference). While utilization rates of outpatient surgery were attenuated, per beneficiary spending and average surgical episode payments increased by 10.4 percent and 7.8 percent, respectively, over the same period. By the end of 2011, Medicare payments for outpatient surgery reached $5.1 billion. Without the policy change, they would have totaled only $4.1 billion. Despite lessening demand, reduced ASC facility payments did not curb spending for outpatient surgery. In fAct, overall payments Actually increased following the policy change, driven by higher average episode payments. © Health Research and Educational Trust.
Laxmaiah Manchikanti - One of the best experts on this subject based on the ideXlab platform.
-
Compliance and Documentation for Interventional Techniques
Essentials of Interventional Techniques in Managing Chronic Pain, 2018Co-Authors: Laxmaiah Manchikanti, Vijay P. Singh, Joshua A HirschAbstract:Compliance and documentation for interventional techniques have a multitude of regulations but are an essential part of medicine. Developments in the mid-1970s irrevocably affected the role of documentation in medicine as a result of a dramatic nationwide increase in medical liability claims and awards and changes in the fledgling Medicare program, followed by the emergence of electronic review progress in the 1980s. The Health Insurance Portability and Accountability Act (HIPAA), the Medicare Modernization Act (MMA), and the Affordable Care Act (ACA), each with numerous component regulations, propelled the growth and importance of documentation to an unimaginable level.
-
the impAct of comparative effectiveness research on interventional pain management evolution from Medicare Modernization Act to patient protection and affordable care Act and the patient centered outcomes research institute
Pain Physician, 2011Co-Authors: Laxmaiah Manchikanti, Helm S Nd, Allan T Parr, Frank J.e. Falco, Ramsin M. Benyamin, Joshua A HirschAbstract:: The Patient-Centered Outcomes Research Institute (PCORI) was established by the Affordable Care Act of 2010 to promote comparative effectiveness research (CER) to assist patients, clinicians, purchasers, and policy-makers in making informed health decisions by advancing the quality and relevance of evidence concerning the manner in which diseases, disorders, and other health conditions can effectively and appropriately be prevented, diagnosed, treated, monitored, and managed through research and evidence synthesis. The development of PCORI is vested in the Medicare Modernization Act (MMA) and the American Recovery and Reinvestment Act (ARRA). The framework of CER and PCORI describes multiple elements which are vested in all 3 regulations including stakeholder involvement, public participation, and open transparent decision-making process. Overall, PCORI is much more elaborate with significant involvement of stakeholders, transparency, public participation, and open decision-making. However, there are multiple issues concerning the operation of such agencies in the United States including the predecessor of Agency for Healthcare Research and Quality (AHRQ), the Agency for Healthcare Policy and Research (AHCPR), AHRQ Effectiveness Health Care programs, and others. The CER in the United States may be described at cross-roads or at the beginnings of a scientific era of CER and evidence-based medicine (EBM). However the United States suffers as other countries, including the United Kingdom with its National Health Services (NHS) and National Institute for Health and Clinical Excellence (NICE), with major misunderstandings of methodology, an inordinate focus on methodological assessment, lack of understanding of the study design (placebo versus Active control), lack of involvement of clinicians, and misinterpretation of the evidence which continues to be disseminated. Consequently, PCORI and CER have been described as government-driven solutions without following the principles of EBM with an extensive focus on costs rather than quality. It also has been stated that the central planning which has been described for PCORI and CER, a term devised to be acceptable, will be used by third party payors to override the physician's best medical judgement and patient's best interest. Further, stakeholders in PCORI are not scientists, are not balanced, and will set an agenda with an ultimate problem of comparative effectiveness and PCORI that it is not based on medical science, but rather on political science and not even under congressional authority, leading to unprecedented negative changes to health care. Thus, PCORI is operating in an ad hoc manner that is incompatible with the principles of evidence-based prActice.This manuscript describes the framework of PCORI, and the role of CER and its impAct on interventional pain management.